Results 1 to 10 of about 1,285,117 (188)

Hyperkalaemia as a Cause of Undertreatment with Mineralocorticoid Receptor Antagonists in Heart Failure

ESC Heart Failure, 2023
Josefin Henrysson
exaly  

Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and Physiology

Biomedicines, 2021
Pereira Ss, Isabel Ferreira, Liliana S Carvalho   +2 more
exaly  

The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists

Kidney International Reports, 2022
Priya Vart, Peter Rossing, Michele Provenzano   +2 more
exaly  

Novel non‐steroidal mineralocorticoid receptor antagonists in cardiorenal disease

British Journal of Pharmacology, 2022
Ulrich Kintscher, George Bakris, Peter Kolkhof   +2 more
exaly  

Mineralocorticoid Receptor Antagonists for Nephroprotection: Current Evidence and Future Perspectives

Current Pharmaceutical Design, 2019
Pantelis Sarafidis, Aikaterini Papagianni, Evangelos Memmos   +2 more
exaly  

The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic Nephropathy

Current Clinical Pharmacology, 2019
Melvin George, Luxitaa Goenka
exaly  

Mineralocorticoid Receptor Antagonists in Primary Aldosteronism

Current Pharmaceutical Design, 2019
Christodoulos Papadopoulos, Konstantinos Stavropoulos, Michael Doumas   +2 more
exaly  

Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis

Europace, 2016
Guangping Li
exaly  

Mineralocorticoid receptor antagonists, a class beyond spironolactone — Focus on the special pharmacologic properties of eplerenone

International Journal of Cardiology, 2015
A D Ristic, Giuseppe Rosano, Nebojsa Lalic   +2 more
exaly  

Emerging cardiovascular indications of mineralocorticoid receptor antagonists

Trends in Endocrinology and Metabolism, 2015
Bertram Pitt, Abdallah Al-Mohammad, Faiez Zannad   +2 more
exaly